Steven J. Keogh

Westmead, NSW, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Revisiting Busulfan-Melphalan Sequencing in Paediatric Solid Tumours: A Pharmacokinetic Signal Beyond Conditioning Sequence.

Revisiting Busulfan-Melphalan Sequencing in Paediatric Solid Tumours: A Pharmacokinetic Signal Beyond Conditioning Sequence.

Journal: Pediatric blood & cancer

Published: August 05, 2026

Physiologically Based Pharmacokinetic Virtual Twin Approach for Fludarabine Dosing in Pediatric Hematopoietic Stem Cell Transplantation.

Physiologically Based Pharmacokinetic Virtual Twin Approach for Fludarabine Dosing in Pediatric Hematopoietic Stem Cell Transplantation.

Journal: CPT: pharmacometrics & systems pharmacology

Published: December 15, 2025

Improved outcome of HSCT in STAT1 gain-of-function disease following JAK inhibition bridging.

Improved outcome of HSCT in STAT1 gain-of-function disease following JAK inhibition bridging.

Journal: Journal of human immunity

Published: October 27, 2025

Allogeneic hematopoietic stem cell transplantation for STAT3 hyper-IgE syndrome: a worldwide study.

Allogeneic hematopoietic stem cell transplantation for STAT3 hyper-IgE syndrome: a worldwide study.

Journal: Blood advances

Published: February 07, 2025

Association of busulfan exposure and outcomes after HCT for patients with an inborn error of immunity.

Association of busulfan exposure and outcomes after HCT for patients with an inborn error of immunity.

Journal: Blood advances

Published: March 28, 2024

The impact of age and renal function on the pharmacokinetics and protein binding characteristics of fludarabine in paediatric and adult patients undergoing allogeneic haematopoietic stem cell transplantation conditioning.

The impact of age and renal function on the pharmacokinetics and protein binding characteristics of fludarabine in paediatric and adult patients undergoing allogeneic haematopoietic stem cell transplantation conditioning.

Journal: European journal of clinical pharmacology

Published: November 24, 2023

Outcomes from hematopoietic stem cell transplantation following treosulfan-based conditioning: A clinical and pharmacokinetic analysis.

Outcomes from hematopoietic stem cell transplantation following treosulfan-based conditioning: A clinical and pharmacokinetic analysis.

Journal: Pediatric transplantation

Published: October 03, 2023

Validation of a liquid chromatography-tandem mass spectrometry method for simultaneous quantification of N,N-dimethylacetamide and N-monomethylacetamide in pediatric plasma.

Validation of a liquid chromatography-tandem mass spectrometry method for simultaneous quantification of N,N-dimethylacetamide and N-monomethylacetamide in pediatric plasma.

Journal: Journal of separation science

Published: December 06, 2022

Low-Level BCR::ABL1 Transcript at Diagnosis in Childhood Leukemia: A 10-Year Single Institution Study.

Low-Level BCR::ABL1 Transcript at Diagnosis in Childhood Leukemia: A 10-Year Single Institution Study.

Journal: Genes, chromosomes & cancer

Published: July 31, 2022

Evaluation of treosulfan cumulative exposure in paediatric patients through population pharmacokinetics and dosing simulations.

Evaluation of treosulfan cumulative exposure in paediatric patients through population pharmacokinetics and dosing simulations.

Journal: British journal of clinical pharmacology

Published: May 19, 2022

Australia and New Zealand Transplant and Cellular Therapies (ANZTCT) position statement: COVID-19 management in patients with haemopoietic stem cell transplant and chimeric antigen receptor T cell.

Australia and New Zealand Transplant and Cellular Therapies (ANZTCT) position statement: COVID-19 management in patients with haemopoietic stem cell transplant and chimeric antigen receptor T cell.

Journal: Internal medicine journal

Published: May 17, 2022

Serotherapy as Graft-Versus-Host Disease Prophylaxis in Haematopoietic Stem Cell Transplantation for Acute Lymphoblastic Leukaemia.

Serotherapy as Graft-Versus-Host Disease Prophylaxis in Haematopoietic Stem Cell Transplantation for Acute Lymphoblastic Leukaemia.

Journal: Frontiers in pediatrics

Published: October 30, 2021

Showing 1-12 of 13

Last Updated: 09/26/2026